FDA Import Refusal 799-5892736-5/2/1 — Glaxosmithkline Peru Sa
The FDA refused shipment 799-5892736-5/2/1 from Glaxosmithkline Peru Sa (Peru) on Jun 14, 2016. The refused product falls under Drugs and Biologics — MISCELLANEOUS PATENT MEDICINES, ETC.. Cited charge: 75 This firm has 5 or more other import refusals on record.
Refusal details
- Date
- Jun 14, 2016
- Country
- Peru
- Product Category
- Drugs and Biologics
- Product Code
- 66VCB99 MISCELLANEOUS PATENT MEDICINES, ETC.
- Charges
- 75